Results summary | View all lists in L2L MDB | View all genes in H02AB.profile.ud50 |
Reduced expression in XPC-defective fibroblasts, compared to normal fibroblasts, following treatment with cisplatin enrichment: 3.90-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
212990_AT | SYNJ1 | T | ![]() |
![]() |
synaptojanin 1 | ||||||||
203140_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
212501_AT | CEBPB | G | D | X | P | R | ![]() |
![]() |
CCAAT/enhancer binding protein (C/EBP), beta | ||||
202437_S_AT | CYP1B1 | E | ![]() |
![]() |
cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||
204589_AT | NUAK1 | P | ![]() |
![]() |
NUAK family, SNF1-like kinase, 1 | ||||||||
203502_AT | BPGM | E | ![]() |
![]() |
2,3-bisphosphoglycerate mutase | ||||||||
202436_S_AT | CYP1B1 | E | ![]() |
![]() |
cytochrome P450, family 1, subfamily B, polypeptide 1 |